Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The primary goal of the study is to evaluate the safety and potential efficacy of intra-oral
dissolvable NH004 films to improve the short-term symptoms of sialorrhea (drooling) in
Parkinson's disease (PD) patients.
Phase:
Phase 2
Details
Lead Sponsor:
NeuroHealing Pharmaceuticals Inc.
Collaborator:
Michael J. Fox Foundation for Parkinson's Research